Hostname: page-component-f554764f5-44mx8 Total loading time: 0 Render date: 2025-04-14T00:32:41.495Z Has data issue: false hasContentIssue false
  • English
  • Français

Anti-Selection is Only the Beginning

Published online by Cambridge University Press:  04 March 2022

Valarie K. Blake  and
Jessica L. Roberts
Get access Rights & Permissions [Opens in a new window]

Abstract

This commentary proposes the need for greater normative debate about when, if ever, it is appropriate for insurers to access genetic information of insureds to combat anti-selection.

Keywords

InsuranceGeneticsDiscriminationHealth StatusGenetic Information Nondiscrimination Act
Type
Independent Articles: Commentary
Information
Journal of Law, Medicine & Ethics , Volume 50 , Issue 1: Health Law and Anti-Racism: Reckoning and Response , Spring 2022 , pp. 155 - 156
Copyright
© 2022 The Author(s)

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Prince et al., “Anti-Selection & Genetic Testing in Insurance,” Journal of Law, Medicine & Ethics 50, no. 1 (2022): 139–154.CrossRefGoogle Scholar
Id., at Part I.Google Scholar
Id., at Part IV(A).Google Scholar
Id., at Part IV(B).Google Scholar
Id., at Part IV(C).Google Scholar
Id., at Part IV(D).Google Scholar
Id.Google Scholar
The authors note that highly penetrant conditions like Huntington’s may be so rare that they will not have a meaningful impact on insurance markets. Id.Google Scholar
Id.Google Scholar